ES2067474T3 - Virus tgev del cerdo como vacuna para perros. - Google Patents

Virus tgev del cerdo como vacuna para perros.

Info

Publication number
ES2067474T3
ES2067474T3 ES88308907T ES88308907T ES2067474T3 ES 2067474 T3 ES2067474 T3 ES 2067474T3 ES 88308907 T ES88308907 T ES 88308907T ES 88308907 T ES88308907 T ES 88308907T ES 2067474 T3 ES2067474 T3 ES 2067474T3
Authority
ES
Spain
Prior art keywords
pork
vaccine
dogs
tgev
viruses
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88308907T
Other languages
English (en)
Inventor
Dale C O Beecham Laborat Bordt
Hans Beecham Inc Beech Draayer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline LLC
Original Assignee
Beecham Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Inc filed Critical Beecham Inc
Application granted granted Critical
Publication of ES2067474T3 publication Critical patent/ES2067474T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A61K39/225—Porcine transmissible gastroenteritis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/265—Infectious rhinotracheitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20061—Methods of inactivation or attenuation
    • C12N2770/20063—Methods of inactivation or attenuation by chemical treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Catalysts (AREA)
  • Saccharide Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)

Abstract

SE DESCUBRE UN METODO PARA PREVENIR EN PERROS LOS CORONAVIRUS CANINOS QUE COMPRENDE LA ADMINISTRACION AL PERRO DE UNA VACUNA VIVA O INACTIVADA PREPARADA DE UNA VIRUS DE LA GASTROENTERITIS TRASMITIBLE PORCINA (UNA VACUNA TGEV). SE DESCRIBE UNA COMPOSICION DE LA VACUNA INACTIVADA PARA SU USO EN CADA METODO Y UN PROCEDIMIENTO PARA LA FABRICACION DE LA COMPOSICION DE LA VACUNA INACTIVADA.
ES88308907T 1987-09-28 1988-09-26 Virus tgev del cerdo como vacuna para perros. Expired - Lifetime ES2067474T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10182287A 1987-09-28 1987-09-28

Publications (1)

Publication Number Publication Date
ES2067474T3 true ES2067474T3 (es) 1995-04-01

Family

ID=22286587

Family Applications (2)

Application Number Title Priority Date Filing Date
ES88308908T Expired - Lifetime ES2061673T3 (es) 1987-09-28 1988-09-26 Inactivacion de virus y bacterias.
ES88308907T Expired - Lifetime ES2067474T3 (es) 1987-09-28 1988-09-26 Virus tgev del cerdo como vacuna para perros.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES88308908T Expired - Lifetime ES2061673T3 (es) 1987-09-28 1988-09-26 Inactivacion de virus y bacterias.

Country Status (14)

Country Link
EP (2) EP0310316B1 (es)
JP (2) JP2733844B2 (es)
KR (2) KR0135426B1 (es)
AT (2) ATE117899T1 (es)
AU (2) AU624339B2 (es)
CA (2) CA1331562C (es)
DE (2) DE3852918T2 (es)
DK (2) DK175308B1 (es)
ES (2) ES2061673T3 (es)
GR (1) GR3015608T3 (es)
IE (2) IE66015B1 (es)
NZ (2) NZ226332A (es)
PT (2) PT88591B (es)
ZA (2) ZA887195B (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3852918T2 (de) * 1987-09-28 1995-07-13 Beecham Inc TGEV-Virus vom Schwein als Impfstoff für Hunde.
DE69020573T3 (de) * 1989-09-25 1999-12-16 Crc Technology Ltd., London Verfahren zur wachstumshemmung von stammzellen.
US5276142A (en) * 1989-12-11 1994-01-04 American Cyanamid Company Process for purification of a 69000 dalton antigenic protein from Bordetella pertussis
EP0674905B1 (en) * 1990-06-07 2002-12-11 Bayer Corporation Bacterin for the treatment of liver necrosis caused by F. necrophorum
US6057436A (en) * 1990-11-14 2000-05-02 Pfizer Inc. Canine coronavirus S gene and uses therefor
US6372224B1 (en) 1990-11-14 2002-04-16 Pfizer Inc. Canine coronavirus S gene and uses therefor
JPH0813753B2 (ja) * 1992-05-22 1996-02-14 株式会社微生物化学研究所 牛伝染性鼻気管炎ウイルス感染症、牛ウイルス性下痢−粘膜病ウイルス感染症、パラインフルエンザ３型ウイルス感染症、牛ｒｓウイルス感染症および牛アデノ７型ウイルス感染症５種混合生ワクチン
WO1994007534A1 (en) * 1992-10-05 1994-04-14 Sanofi Animal Health, Inc. High potency vaccines
JP2521226B2 (ja) * 1993-01-28 1996-08-07 株式会社微生物化学研究所 犬用多種混合ワクチン
US5750112A (en) * 1993-02-26 1998-05-12 Solvay Animal Health, Inc. Canine coronavirus vaccine from feline enteric coronavirus
EP0612532A3 (en) * 1993-02-26 1998-02-04 Solvay Animal Health, Inc. Canine coronavirus vaccine from feline enteric coronavirus
US5362442A (en) 1993-07-22 1994-11-08 2920913 Canada Inc. Method for sterilizing products with gamma radiation
AU677090B2 (en) * 1993-08-06 1997-04-10 Connaught Laboratories Limited Inactivated respiratory syncytial viral vaccines
CA2184132C (en) 1995-09-21 2011-03-15 Kristina J. Hennessy An adjuvanted vaccine which is substantially free of non-host albumin
US6682746B2 (en) 1995-09-21 2004-01-27 Kristina J. Hennessy Adjuvanted vaccine which is substantially free of non-host albumin
US5853715A (en) * 1996-08-16 1998-12-29 Bayer Corporation Cross-protective equine herpesvirus preparations and method of making and using the same
UA78180C2 (uk) * 1997-10-03 2007-03-15 Меріаль Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти
EP0978286A1 (en) * 1998-08-07 2000-02-09 Bayer Corporation Cross-protective equine herpesvirus preparations and method of making and using the same
US6682695B2 (en) 2001-03-23 2004-01-27 Clearant, Inc. Methods for sterilizing biological materials by multiple rates
US6696060B2 (en) 2001-06-14 2004-02-24 Clearant, Inc. Methods for sterilizing preparations of monoclonal immunoglobulins
US6946098B2 (en) 2001-08-10 2005-09-20 Clearant, Inc. Methods for sterilizing biological materials
US7252799B2 (en) 2001-08-31 2007-08-07 Clearant, Inc. Methods for sterilizing preparations containing albumin
US6749851B2 (en) 2001-08-31 2004-06-15 Clearant, Inc. Methods for sterilizing preparations of digestive enzymes
US20030095890A1 (en) 2001-09-24 2003-05-22 Shirley Miekka Methods for sterilizing biological materials containing non-aqueous solvents
US6783968B2 (en) 2001-09-24 2004-08-31 Clearant, Inc. Methods for sterilizing preparations of glycosidases
US6908591B2 (en) 2002-07-18 2005-06-21 Clearant, Inc. Methods for sterilizing biological materials by irradiation over a temperature gradient
US7682619B2 (en) 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
CN103709248B (zh) * 2013-12-24 2019-07-16 北京大北农科技集团股份有限公司动物医学研究中心 一种抗猪传染性胃肠炎病毒高免血清及其制备方法
DE202020001666U1 (de) 2020-04-21 2020-06-08 Walther Enßlin Imprägnierung der Oberfläche von Kleidung, Schutzkleidung, Gewebehandschuhen gegen Viren aus den Tröpfchen der Atemluft
DE202020003865U1 (de) 2020-09-11 2021-09-22 Karin Emde Einfangen und Vernichten von Viren und andere Mikroorganismen in Raumluft und Raumluftfiltern
DE102021001635A1 (de) 2021-03-27 2022-09-29 Karin Emde Abfangen und Vernichten von Viren und andere Mikroorganismen auf Oberflächen, in Raumluft, in der Abluft von Staubsaugern und in Raumluftfiltern.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3145144A (en) * 1951-08-09 1964-08-18 Takeda Pharmacentical Ind Ltd Process for manufacturing chromium treated vaccines
FR1488212A (fr) * 1964-06-22 1967-07-13 Behringwerke Ag Procédé permettant d'atténuer le virus de la fièvre aphteuse
DE1253412B (de) * 1964-09-22 1967-11-02 Diamond Lab Inc Verfahren zur Gewinnung eines Impfstoffes gegen infektioese Schweinegastroenteritis
US3925544A (en) * 1971-07-12 1975-12-09 Univ Southern Illinois Bovine vaccines and methods of making and using same
US3907986A (en) * 1972-12-18 1975-09-23 Rit Rech Ind Therapeut Live attenuated infectious bovine rhinotracheitis virus vaccines and preparation thereof
JPS5531762B2 (es) * 1973-03-28 1980-08-20
EP0000677B1 (en) * 1977-07-22 1981-08-05 Merck & Co. Inc. Parainfluenza virus vaccine and its preparation
JPS55104215A (en) * 1979-02-06 1980-08-09 Merck & Co Inc Parainfluenza virus vaccine and its manufacture
GB8502399D0 (en) * 1985-01-31 1985-03-06 Akzo Nv Canine parvovirus vaccines
DE3852918T2 (de) * 1987-09-28 1995-07-13 Beecham Inc TGEV-Virus vom Schwein als Impfstoff für Hunde.

Also Published As

Publication number Publication date
NZ226333A (en) 1991-09-25
ATE117899T1 (de) 1995-02-15
EP0310316A3 (en) 1990-02-14
IE882908L (en) 1989-03-28
DE3886332D1 (de) 1994-01-27
DK175308B1 (da) 2004-08-16
JPH01230523A (ja) 1989-09-14
DK534288D0 (da) 1988-09-26
IE60950B1 (en) 1994-09-07
AU2284388A (en) 1989-04-06
EP0310316B1 (en) 1995-02-01
JPH01230532A (ja) 1989-09-14
DK534188D0 (da) 1988-09-26
KR890004728A (ko) 1989-05-09
EP0310317B1 (en) 1993-12-15
DE3852918D1 (de) 1995-03-16
PT88590A (pt) 1988-10-01
CA1332919C (en) 1994-11-08
KR890004725A (ko) 1989-05-09
DK534288A (da) 1989-03-29
IE66015B1 (en) 1995-11-29
EP0310317A3 (en) 1990-02-14
NZ226332A (en) 1991-10-25
ZA887195B (en) 1989-07-26
AU2281488A (en) 1989-04-06
DE3852918T2 (de) 1995-07-13
ES2061673T3 (es) 1994-12-16
JP2715114B2 (ja) 1998-02-18
PT88591A (pt) 1988-10-01
GR3015608T3 (en) 1995-06-30
DK175379B1 (da) 2004-09-20
EP0310316A2 (en) 1989-04-05
IE882909L (en) 1989-03-28
PT88590B (pt) 1993-04-30
CA1331562C (en) 1994-08-23
DE3886332T2 (de) 1994-03-31
JP2733844B2 (ja) 1998-03-30
EP0310317A2 (en) 1989-04-05
ZA887196B (en) 1989-07-26
AU624081B2 (en) 1992-06-04
DK534188A (da) 1989-03-29
ATE98680T1 (de) 1994-01-15
PT88591B (pt) 1992-11-30
AU624339B2 (en) 1992-06-11
KR0135426B1 (ko) 1998-04-23

Similar Documents

Publication Publication Date Title
ATE117899T1 (de) Tgev-virus vom schwein als impfstoff für hunde.
DE69635871T2 (de) Verfahren und Zusammensetzungen zur selektiven Modikation von Nukleinsäuren
ATE366312T1 (de) Impfstoff und antitoxine zur behandlung und vorbeugung von c. difficile krankheiten
ES2077028T3 (es) Vacunas vivas.
CY1105221T1 (el) Ιατρικη χρηση θυρεοειδομιμητικων ενωσεων για την θepαπευτικη αγωγη της τριχοπτωσης και φαρμακευτικες συνθεσεις
DK0650733T3 (da) Levende svækket in ovo-vaccine
ATE92343T1 (de) Sterilisation von behaeltern mittels wasserstoffperoxid, persaeuren und uv-strahlung.
CA2022420A1 (en) Escherichia coli vaccine
PT1140113E (pt) Utilizacao de bisfosfonatos para profilaxia e tratamento de processos infecciosos
BR9913990A (pt) Uso de compostos organofosforados para a produção de preparações farmacêuticas para o tratamento terapêutico e profilático de infecções ou como um fungicida, bactericida ou herbicida em plantas
DK0684842T3 (da) Præparat til behandling af tumorer og immunisering af organismer over for tumorer
HUP9700975A2 (hu) Élő, legyengített, Pasteurellaceae családba tartozó, RTX-termelő baktériumok
ES2162862T3 (es) Uso de la timosina para tratar la hepatitis c en pacientes que no responden al tratamiento con interferon.
RU2392003C2 (ru) Способ получения сальмонеллезной вакцины
ATE16348T1 (de) Ozon-inaktivierte keime als vakzine.
LI et al. Research progress on the mechanism of transmission, pathopoiesis, treatment and prevention of avian influenza virus (H5N1)
MX9400210A (es) Tratamiento de infecciones virales.
SU1565027A1 (ru) Инактиватор вируса западного нила
GB1091245A (en) Method for inducing resistance to viral infections in an animal
RO86744B1 (ro) Vaccin antisalmonelic aviar

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 310316

Country of ref document: ES